Cargando…
Sodium channel-inhibiting drugs and cancer survival: protocol for a cohort study using the CPRD primary care database
INTRODUCTION: Voltage-gated sodium channel (VGSC)-inhibiting drugs are commonly used to treat epilepsy and cardiac arrhythmia. VGSCs are also widely expressed in various cancers, including those of the breast, bowel and prostate. A number of VGSC-inhibiting drugs have been shown to inhibit cancer ce...
Autores principales: | Fairhurst, Caroline, Martin, Fabiola, Watt, Ian, Doran, Tim, Bland, Martin, Brackenbury, William J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020752/ https://www.ncbi.nlm.nih.gov/pubmed/27601493 http://dx.doi.org/10.1136/bmjopen-2016-011661 |
Ejemplares similares
-
Exposure to sodium channel-inhibiting drugs and cancer survival: protocol for a cohort study using the QResearch primary care database
por: Fairhurst, Caroline, et al.
Publicado: (2014) -
Sodium channel-inhibiting drugs and cancer-specific survival: a population-based study of electronic primary care data
por: Fairhurst, Caroline, et al.
Publicado: (2023) -
Sodium channel-inhibiting drugs and survival of breast, colon and prostate cancer: a population-based study
por: Fairhurst, Caroline, et al.
Publicado: (2015) -
Therapeutic Value of Voltage-Gated Sodium Channel Inhibitors in Breast, Colorectal, and Prostate Cancer: A Systematic Review
por: Martin, Fabiola, et al.
Publicado: (2015) -
Comparison of antibiotic prescribing records in two UK primary care electronic health record systems: cohort study using CPRD GOLD and CPRD Aurum databases
por: Gulliford, Martin C, et al.
Publicado: (2020)